Abstract
The future of rosacea treatment will depend on developing an understanding of the aetiology and pathogenesis of the various components that result in this common cutaneous disorder. Appropriate therapy can then be directed at causative factors with the objective of preventing the development of the more florid manifestations of the disease. Until that knowledge is available treatment will be directed at the different clinical features that present in rosacea patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Powell FC. Rosacea. N Engl J Med. 2005;352:793–803.
Bergfeld WF, Fowler JF, Baumann LS, Taylor SC. The four seasons of skin care: the utility of natural ingredients. Cosmet Dermatol. 2004;17(12 S4):1–9.
Butterwick KJ, Butterwick LS, Han A. Laser and light therapies for acne rosacea. J Drugs Dermatol. 2006;5:35–9.
Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective alpha1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol. 2007;143:1369–71.
Nybaek H, Jamec GB. Photodynamic therapy in the treatment of rosacea. Dermatology. 2005;211:135–8.
Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol. 2007;57:873–8.
Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004;51:499–512.
Auada-Souto MP, Velho PE. Low-strength trichloroacetic acid in the treatment of rosacea. J Eur Acad Dermatol Venereol. 2007;21:1443–5.
Mc Aleer MA, Powell FC. Complementary and alternative medicine usage in rosacea. Br J Dermatol. 2008;158:1139–41.
Wu J. Treatment of rosacea with herbal ingredients. J Drugs Dermatol. 2006;5:29–32.
Wu JJ, Weinstein GD, Kricorian GJ, Kormeili T, McCullough JL. Topical kinetin 0.1% lotion for improving the signs and symptoms of rosacea. Clin Exp Dermatol. 2007;32:693–5.
Wilkin J, Dahl M, Detemar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46:584–7.
Wolf K. Present and future rosacea treatment. Cutis. 2005;75:4–7.
Drott C, Claes G, Olsson-Rex L, Dalman P, Fahlén T, Göthberg G. Successful treatment of facial blushing by endoscopic transthoracic sympathicotomy. Br J Dermatol. 1998;138:639–43.
Nestor MS, Gold MH, An K, et al. The use of PDT in dermatology: results of a consensus conference. J Drugs Dermatol. 2006;5:140–54.
Irvine C, Kumer P, Marks R. Isotretinonin in the treatment of roscaea and rhinophyma. In: Marks R, Plewig G, editors. Acne and related disorders. London: Martin Dunitz; 1998. p. p301–5.
el-Azhary RA, Roenigk RK, Wang TD. Spectrum of results after treatment of rhinophyma with the carbon dioxide laser. Mayo Clin Proc. 1991;66:899–905.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Powell, F.C., McAleer, M.A. (2014). The Future of Rosacea Treatment. In: Zouboulis, C., Katsambas, A., Kligman, A. (eds) Pathogenesis and Treatment of Acne and Rosacea. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69375-8_98
Download citation
DOI: https://doi.org/10.1007/978-3-540-69375-8_98
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69374-1
Online ISBN: 978-3-540-69375-8
eBook Packages: MedicineMedicine (R0)